Xarelto Can Increase Risk of Bleeding, Hematomas, Stroke and More
Topics: Health, Health News, FDA, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Ryan Foster, Foster & Houston, Xarelto, Xarelto Lawsuit
Topics: IVC Filter, Health News, Medical, Medical News, The Law Offices of Foster & Houston, IVC Lawsuit, Ryan Foster, Foster & Houston, IVC Filter Lawsuit, Medical Update
Study Finds Use of PPI Drugs for Heartburn Could Lead to Severe Kidney Damage
Topics: Health News, Heartburn, Kidney Disease, Kidney Damage, The Law Offices of Foster & Houston, Nexium, FANDHLAW, Nexium Lawsuit, Prilosec, PPI, PPI Lawsuit, Heartburn Drug Lawsuit, Ryan Foster, Foster & Houston, Heartburn Drugs, Prilosec Lawsuit, GERD Drug, GERD Drugs
Harvard Health: Higher Bleeding Risk Associated with Pradaxa
A study covered in the Harvard Health Publications blog finds Pradaxa users have a higher bleeding risk compared to Warfarin users. In this post, Howard LeWine, M.D., discusses Pradaxa research and shares his professional opinion about blood-thinners.
Topics: Health, Health News, Pradaxa, FDA, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Pradaxa Lawsuit, Ryan Foster, Foster & Houston, Mechanical Heart Valves, Juliet Foster, Julie Foster, Harvard Health
New Technology Could Help Burn Victims Regrow Skin for a Faster Recovery
Topics: Health News, Science, Burn Injury, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Burn Lawsuit, Ryan Foster, Foster & Houston, Burn Technology, Burn Injury Lawsuit
Actos Linked to Bladder Cancer: What You Need to Know
Actos, a drug prescribed to help control blood sugar levels in those with Type 2 diabetes, has been linked to a number of catastrophic health complications including bladder cancer. The FDA has announced that use of Actos for more than one year may be associated with an increased risk of bladder cancer and death.
Topics: Health, Health News, Actos, Bladder Cancer, Actos Lawsuit, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Ryan Foster, Foster & Houston
Federal Panel Addresses Concerns Over Dangerous Bleeding Related to Xarelto
In 2012, a federal advisory panel voted against expanding the use of the anticoagulant drug Xarelto. According to the New York Times, the panel found that dangerous bleeding associated with Xarelto outweighed evidence that the drug helps reduce the risk of blood clots.
Topics: Health, Health News, FDA, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Ryan Foster, Foster & Houston, Xarelto, Xarelto Lawsuit
The FDA has received multiple reports of product issues and adverse events associated with IVC filters. In fact, from 2005 to 2010 alone the FDA received 921 device adverse event reports.
Topics: IVC Filter, Health News, Medical, Medical News, The Law Offices of Foster & Houston, IVC Lawsuit, Ryan Foster, Foster & Houston, IVC Filter Lawsuit, Medical Update
Use of Pradaxa Restricted in Patients with Mechanical Heart Valves
Pradaxa should not be used to prevent stroke or blood clots in patients with medical heart valves, according to the U.S. Food and Drug Administration (FDA). In this safety communication the FDA states Pradaxa users with mechanical prosthetic heart valves are more likely to experience stroke, heart attack, and blood clots than Warfarin users.
Topics: Health, Health News, Pradaxa, FDA, Health Study, Health Research, The Law Offices of Foster & Houston, FANDHLAW, Pradaxa Lawsuit, Ryan Foster, Foster & Houston, Mechanical Heart Valves
How Well-Known Were the Dangers of a Deadly Blood-Clot Filter?
Topics: IVC Filter, Health News, The Law Offices of Foster & Houston, IVC Lawsuit, Ryan Foster, Foster & Houston, IVC Filter Lawsuit